Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study

T Taigo Kato Y Yasutomo Nakai M Mototaka Sato T Tetsuya Takao T Toshichika Iwanishi S Shingo Toyoda H Hiroki Osaki M Masao Tsujihata K Koichi Okada K Kenichi Kakimoto H Hiromu Horitani Y Yutaka Ono K Kensaku Nishimura S Shingo Takada K Kazutoshi Fujita H Hitoshi Takayama O Osamu Miyake M Masashi Nakayama Y Yu Ishizuya T Takuji Hayashi Y Yoshiyuki Yamamoto K Koji Hatano A Atsunari Kawashima N Norio Nonomura

Article Details

Volume / Issue Vol. 15, Issue 1
Published December 12, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (24)

T

Taigo Kato

Y

Yasutomo Nakai

M

Mototaka Sato

T

Tetsuya Takao

T

Toshichika Iwanishi

S

Shingo Toyoda

H

Hiroki Osaki

M

Masao Tsujihata

K

Koichi Okada

K

Kenichi Kakimoto

H

Hiromu Horitani

Y

Yutaka Ono

K

Kensaku Nishimura

S

Shingo Takada

K

Kazutoshi Fujita

H

Hitoshi Takayama

O

Osamu Miyake

M

Masashi Nakayama

Y

Yu Ishizuya

T

Takuji Hayashi

Y

Yoshiyuki Yamamoto

K

Koji Hatano

A

Atsunari Kawashima

N

Norio Nonomura